Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

CNST Stock Is Particularly Risky After Its Recent Run

By Josh Enomoto, InvestorPlace Contributor

Enjoying a blistering run within the last two months, CNST stock has quickly attracted eyeballs. But with such strong momentum, investors shouldn’t lose sight of the tough fundamental picture for pharmaceutical companies.

Ocugen Stock Is Nothing More than a Risky Trade on Even-riskier Biotech

By Josh Enomoto, InvestorPlace Contributor

Ocugen gave rise to OCGN stock through a reverse merger with Histogenics. But despite this confusing deal, it really didn't do much for either company in the end.

Favorable Timing in Q3 Should Lift Home Depot Stock

By Josh Enomoto, InvestorPlace Contributor

Just because Home Depot stock has performed well doesn’t mean it’s going to correct anytime soon, as its Q3 report may reveal.

Economic Fundamental Issues Aside, IQ Stock Has an Identity Crisis

By Josh Enomoto, InvestorPlace Contributor

In some ways, iQiyi stock is the worst of both worlds: it has the fading revenue growth of an irrelevant stalwart but none of the core attributes of a value stock, such as a high dividend yield.

3 Pros, 3 Cons to Buying Plug Power Stock as World Pivots from Fossil Fuels

By Josh Enomoto, InvestorPlace Contributor

Undoubtedly, alternative energy investments like PLUG stock are appealing due to their paradigm-shattering potential. At the same time, many significant challenges stand in the way.

Download Some Profits From Zynga Stock

By Josh Enomoto, InvestorPlace Contributor

For the most part, Zynga nailed its Q3 report, bolstering ZNGA stock. Still, some important details suggest caution is the best approach.

7 Silver and Gold Stocks to Buy That Offer Contrarian Upside

By Josh Enomoto, InvestorPlace Contributor

Although the markets are seemingly bullish on current developments, this is perhaps the best time to go contrarian with gold stocks to buy.

Beneath the Q3 Setback Is an Opportunity for CRON Stock

By Josh Enomoto, InvestorPlace Contributor

The third quarter earnings season isn’t getting off on the right foot for Cronos Group stock. Still, a key pivot toward the U.S. CBD market could be one of the hidden catalysts for a recovery.

3 Pros, 3 Cons for New Age Beverages Stock

By Josh Enomoto, InvestorPlace Contributor

NBEV stock has the potential to dominate the CBD-infused beverages market. But legal and competitive problems shouldn’t be ignored.

Why Google Stock Is Primed for Even More Dominance

By Josh Enomoto, InvestorPlace Contributor

Very few people enjoy buying shares near their all-time highs. But for GOOG stock, an exception can be made. With expanding businesses and key acquisitions, Alphabet can become a dominant force in the end-user digital ecosystem.

Load More